. However, it is clear that under experimental conditions, cell identity can be altered. In the late 19 th century, researchers described transdifferentiation of the newt iris into lens following surgical removal of the lens 2 . The potential of fully mature adult cells to dramatically change their identity was further revealed in the 1950s and 1960s by John Gurdon, who showed that terminally differentiated cells could -under extreme experimental conditions of nuclear transplantation (during which the nucleus of the somatic cell was transplanted in an enucleated egg) -be converted into cells with the properties of a fertilized egg 3 . At around the same time, work by Ernest Hadorn and others showed that cells in the fly imaginal disc could 'transdetermine' and acquire a new adult fate following transplantation 4 . Since these pioneering experiments, cellular plasticity has been the focus of intense investigation.
Cellular conversions fall into two major categories: de-differentiation and transdifferentiation 5 . De-differentiation refers to the reversion of a committed or differentiated cell (defined by the expression of differentiation markers or other features of a specialized cell) into a cell with greater developmental potential, such as a stem cell or a progenitor cell 6 (FIG. 1a,b) . The most dramatic example of this is the derivation of induced pluripotent stem cells (iPSCs), during which the overexpression of a limited number of transcription factors can induce terminally differentiated cells to become pluripotent in vitro 7 . Transdifferentiation, by contrast, refers to the conversion of one differentiated cell type into another, either within or across germ layers (FIG. 1c) . Such inter conversions may involve a de-differentiation step, whereby cells go through a primitive stem-like state, or they may involve a more direct route, bypassing such stem-like intermediates. The activity of myoblast determination protein (MYOD) -a basic helix-loop-helix transcription factor that can convert fibroblasts, chondrocytes, retinal pigmented epit helial cells and other cell types into muscle when ectopically expressed -is an example of the latter process 8, 9 . Although these experimental methods for manipulating cell identity have been the focus of most mammalian plasticity studies, it seems that cell identity can also change under 'natural' conditions 6 , in response to either intrinsic changes to the cell or changes in the surrounding environment and signals (see BOX 1 for a discussion of in vivo and in vitro cellular plasticity). In marine animals, cellular de-differentiation and transdifferentiation constitute part of the organism's normal response to injury 
Epimorphosis
Morgan's term for regeneration using cellular proliferation.
Morphyllaxis
Morgan's term for regeneration using existing material in the animal, without relying on proliferation.
Lineage tracing
Tracing the progeny and fate of a population of cells using permanent labelling.
remains to be determined on a case-by-case basis, the existence of many examples of the phenomenon throughout the animal kingdom implies that it has a conserved role in tissue homeostasis and repair. In this Review, we focus on such 'physiological' reprogramming, using examples from mammalian and non-mammalian systems to understand how and why cells change their identity during a normal injury response. Implicit in this is the belief that understanding such processes at the cellular and molecular levels will foster greater insight into diseases that involve cellular plasticity -including cholestatic liver injury, diabetes and neural injuries -and thus facilitate the development of novel therapies that make use of cell replacement.
Epimorphosis and de-differentiation
More than a century ago, Thomas Hunt Morgan made a distinction between regenerative processes that utilized cellular proliferation (which he termed epimorphosis) and those that did not (which he termed morphyllaxis) 12 . Over time, epimorphosis has come to refer to those regenerative processes involving cellular de-differentiation and re-differentiation (typically involving proliferation), in which cells return to their original identity, whereas morphyllaxis is used to refer to regeneration involving the transdifferentiation of cells from one identity to another (FIG. 1) . With the advent of refined microscopy and tools for lineage tracing, it has become apparent that both forms of cellular plasticity, de-differentiation and trans differentiation, can contribute to tissue regener ation in various settings. Two other types of regeneration, which are not discussed here as they involve compensatory reconstitution of mass without changes in cell identity, are referred to as hypertrophy and hyperplasia and involve the growth or replication of existing differentiated cells, respectively 13 . Examples of de-differentiation have been found across model organisms in response to injury and cell loss. This indicates a probable evolutionary advantage in being able to replace stem cells and progenitor cells from more-differentiated cells.
De-differentiation in invertebrates.
One of the beststudied examples of cellular plasticity is the Drosophila melanogaster testis. During de-differentiation, cells with a more specialized differentiation state revert back to a more progenitor-like or stem cell-like identity that is characterized by the expression of immature cell markers and stem-like functional properties, including self-renewal and the capacity to produce differentiated spermatids 6 . In the fly testis, germline stem cells (GSCs) reside near a specialized niche known as the 'hub' (FIG. 2a) , which provides the environment and signals that are necessary for stem cell maintenance. In this niche, the GSCs either divide to give rise to more GSCs or differentiate to give rise to gonialblasts, which differentiate into spermatogonia and the spermatocyte lineage 14 . As GSCs rely on STAT (signal transducer and activator of transcription) signalling for maintenance 15, 16 , it was possible to deplete the niche of GSCs by genetically removing STAT signalling 17 . Remarkably, when this was done, new fully functional GSCs emerged through de-differentiation of gonialblasts and spermatogonia following restoration of STAT signalling 17 . De-differentiation, as marked by repopulation of the GSC niche and remnants from spermatogonia cysts breaking up to form single cells, was also seen following other methods of GSC ablation. Loss of GSCs by forced differentiation through ectopic expression of the differentiation factor bag of marbles (Bam) 18 induced de-differentiation, suggesting that de-differentiation was triggered by a decrease in the size of the stem cell pool rather than as a consequence of altered STAT signalling. Although gonialblasts and spermatogonia can become GSCs following this transient ablation, spermatocytes cannot do so 17 , a finding that probably reflects changes in chromatin that impose a barrier to de-differentiation. Moreover, de-differentiation also seems to be conserved in mammals, as spermatogonia cultured in the presence Transdifferentiation may occur either directly, without any reversion to immature phenotypes, or through a de-differentiation step before cells re-differentiate to a new mature phenotype.
Schwann cells
Cells that surround and envelope neurons in myelin sheaths, allowing for proper conduction along the nerve.
Lateral plate mesoderm
A developmental division of mesoderm that gives rise to tendon, bone, connective tissue and dermis within the vertebrate limb.
Multinucleated myofibres
Syncytial muscle fibres formed from many muscle progenitors that fuse together to generate a single fibre with many nuclei.
Satellite cells
PAX7 + muscle stem cells that reside next to muscle fibres and mediate muscle regeneration in many vertebrate species.
Sarcomere apparatus
Actin, myosin and associated proteins within mature muscle fibres that are organized in such a way that they can move relative to each other to produce muscle contractions.
of glial cell line-derived neurotrophic factor (GDNF) and fibroblast growth factor 2 (FGF2) can regenerate the mammalian GSC niche 19, 20 . A similar phenomenon takes place in the D. melanogaster ovary following forced differentiation of GSCs 21 .
De-differentiation in amphibians and teleosts.
Amphibian limb regeneration is the archetypal example of epimorphic regeneration. Following limb amputation, differentiated cells near the amputation site undergo de-differentiation and stem cells are activated to produce a pool of proliferating progenitors known as a blastema. The blastema will ultimately produce all of the tissues of a fully regenerated limb. Originally the blastema was thought to consist of pluripotent cells that could give rise to many limb tissues 22, 23 ; however, more recent studies have suggested that this apparent plasticity of the stem cell pool may have been due to sample contamination. In particular, one study using lineage-specific labelling found that the blastema is not composed of a homogenous pool of pluripotent cells but instead contains a heterogeneous mix of lineage-restricted progenitors; for example, muscle-derived blastemal cells only produced muscle, and Schwann cells only gave rise to new Schwann cells 24 . Although the dermis showed some adaptability in cell fate, the new cell fates that originated from dedifferentiation of the dermis were restricted to fates that, like dermis, originate from the lateral plate mesoderm developmentally, suggesting that any de-differentiation that occurs remains partially lineage-restricted within lateral plate mesoderm 24 . Genetic lineage-tracing techniques have also demonstrated distinct species-specific mechanisms of regeneration. For example, applying the technique in urodele salamanders showed that limb amputation in the newt Notophthalmus viridescens induced de-differentiation of multinucleated myofibres into proliferating mononuclear cells to generate new muscle in the regenerating limb. However, the axolotl Ambystoma mexicanum does not de-differentiate myofibres but instead relies on paired box protein 7 (Pax7) + satellite cells, which are quiescent muscle stem cells, to regenerate limb muscle 25 . Importantly, this study found that the newt blastema did not contain Pax7 + cells, demonstrating that even within amphibians, different species can use different mechanisms to regenerate lost tissue.
De-differentiation also contributes to heart regeneration in the zebrafish Danio rerio. Zebrafish can regrow heart tissue following amputation of up to 20% of the left ventricle 26 . In response to amputation, differentiated cardiomyocytes disassemble their sarcomere apparatus, repress sarcomeric genes and induce expression of genes involved in cell proliferation 27, 28 .
De-differentiation in mammals.
Tissue regeneration occurs to a more limited extent in mammals than it does in amphibians and invertebrates. Nevertheless, several examples of de-differentiation during mammalian regeneration have recently come to light, including skin, intestine, lung and nervous system (additional information on plasticity in the skin and intestine can be found in two recent reviews 29, 30 ). During hair growth, the hair-producing cells within the follicle are derived from three progenitor populations -the quiescent, slow-cycling upper bulge stem cells, the proliferative lower bulge stem cells that form the outer root sheath, and the associated hair germ cells (FIG. 2b) . The cells of the hair germ give rise to the majority of differentiated hair cells during a normal growth cycle. Specifically, hair germ cells undergo more divisions than bulge cells 31 and give rise to the rapidly and asymmetrically dividing 'transit-amplifying' cells in the matrix that make the hair 32 . However, the hair germ itself does not contribute to another hair cycle. Instead, with each cycle, a small number of upper bulge stem cells repopulate the lower bulge, of which a small number of cells will regenerate the hair germ in preparation for a new cycle. Thus, the hair follicle seems to contain a stem cell hierarchy -akin to that of GSCs and spermatogonia in the D. melanogaster testis -whereby bulge cells constitute an alternative source of stem cells that can give rise to the hair germ. The environment around the stem cells, known as the stem cell 'niche' , seems to be crucial in determining their fate, as location dictates fate in a stereotypical fashion 33 . Although the signals inducing these stem cell fates are unclear, the slow-cycling upper cells in the outer root sheath typically repopulate the bulge. The lower outer root sheath cells typically lose their stem cell characteristics, and although most of these cells undergo apoptosis, some cells contribute to the new hair germ 32 . Similar to the fly testis, hair germ cells are able to repopulate the niche following bulge cell ablation 33 . Although hair germ cells are still close in nature to bulge cells, following bulge ablation they seem to take on a more progenitor-like fate and can function as bulge cells, fuelling further hair cycles 33 . In addition to the hair germ, cells situated in epithelial compartments above the bulge, which are normally maintained by a separate stem cell population 34, 35 , also contribute cells to the new bulge 33 .
Box 1 | Criteria for evaluating cellular plasticity
In the initial enthusiasm over cell plasticity studies at the beginning of this century, many studies reported that cells could undergo extreme changes in identity, crossing developmental germ layers as neurons became blood cells 111 and bone marrow cells produced hepatocytes 112 . These remarkable claims were based largely on studies conducted in vitro or that utilized transplantation under extreme experimental conditions. As these studies came under criticism for problems with reproducibility or their relevance to the physiological in vivo situation 5 , it became clear that better criteria were needed to support claims of de-differentiation or transdifferentiation 54 . Among these were the requirements that cells be clearly identified before and after fate change, that they be functional in their new fate and that they be properly integrated in the tissue 54 . Thus, although it is true in principle that there are no absolute limits to cellular plasticity (as any cell can be reprogrammed to a pluripotent state, which in turn can give rise to any other cell type), claims of cellular plasticity -like any scientific assertion -need to be assessed with caution. Is the conversion taking place in vitro or in vivo? What assays are being used to assess cell identity? Are de-differentiation and/or transdifferentiation occurring under experimental or physiological conditions? Although experimentally mediated transdifferentiation may have important applications in the future (TABLE 2) , such findings do not necessarily represent normal paths to plasticity in vivo. Researchers have also studied how entire follicles may be regenerated following damage. Most skin injuries lead to scarring, generating an epithelium without hair follicles and glands. However, in two species of African spiny mouse -Acomys kempi and Acomys percivali -injured skin regenerates fully, including follicles and glands, without scarring. The mechanism of this is not clear, but there are interesting features of skin regeneration in Acomys spp. that may provide clues. Specifically, physical features of Acomys spp. skin allows it to be shed during damage, causing the emergence of a blastema-like structure, which is organized similarly to the blastema that arises following amphibian limb amputation 36 . It is thus enticing to speculate that Acomys spp. skin regeneration involves a de-differentiation step, allowing the repair to occur in a scar-free manner.
De-differentiation also occurs in the intestine follow ing injury (FIG. 2c) . The intestinal crypts contain stem cells that self-renew and produce the intestinal epithelium, including transit-amplifying, absorptive and secretory cell types 37, 38 . These stem cells give rise to committed progenitor cells, including delta-like protein 1 (DLL1) + crypt cells that differentiate exclusively along the secretory lineage 39 . However, after exposure to radiation -which eliminates Leu-rich repeatcontaining G protein-coupled receptor 5 (LGR5) + stem cells -DLL1
+ secretory precursor cells have been reported to de-differentiate into LGR5 + stem cells, which can subsequently generate all of the cell types of the intestinal epithelium 39 . Consistent with this notion, another study found that slow-cycling LGR5 + labelretaining cells (LRCs), located at the top of the stem cell zone, have the capacity to repopulate the stem cell niche after injury and give rise to all intestinal cell types 40 . These studies demonstrate that, following injury, intestinal progenitor cells de-differentiate into functional crypt stem cells, presumably to aid in the regenerative response. Similarly, a recent study of stomach stem cells found that differentiated enzyme-secreting cells expressing tumour necrosis factor receptor superfamily member 19 (TROY + chief cells) in the crypts can de-differentiate following injury and contribute to all crypt cell types, thereby functioning as an alternative stem cell population 41 . Following this paradigm, the lung (FIG. 2d) also utilizes de-differentiation to generate new stem cells in the airway epithelium following stem cell ablation. The tracheal airway is a pseudostratified epithelium, with cytokeratin 5 (CK5) + basal cells located in close contact with the basal lamina 42, 43 . These basal cells function as stem cells, as they can self-renew and give rise to both secretory and ciliated lineages 44 , and basal cell proliferation and differentiation is dramatically increased following airway injury 45 . If, however, CK5 + basal cells are ablated, cells from the secretory lineage can de-differentiate to give rise to new basal cells; such cells have the full phenotypical and functional characteristics of airway stem cells 46 (FIG. 2d) .
Finally, de-differentiation is a component of the injury response in the nervous system. Following nerve injury and the ensuing inflammatory response, mature Schwann cells take on an immature phenotype, downregulating myelin-associated factors and expressing growth factors and pro-regenerative factors to support axonal repair (FIG. 2e) . Once de-differentiated Schwann cells make contact with neurons, the cells re-differentiate and myelinate axons again 47 . Blocking of Schwann cell de-differentiation, either experimentally or as a result of ageing, impairs neural regeneration 48 .
Mechanisms of de-differentiation
In the examples discussed above, de-differentiation is a physiological response to tissue injury or cell ablation. As this does not occur under homeostatic conditions but only following perturbation, differentiated cells must either be exposed to new signals that cause dedifferentiation or be released from signals that normally inhibit their reversion. It seems that distinct molecular mechanisms, involving both cell-autonomous and non-cell-autonomous factors, control cell identity in different systems.
Competence to de-differentiate. Competence, which is the intrinsic ability of a cell to respond to certain signals, is a prerequisite for cellular de-differentiation. In newt limb regeneration, de-differentiation involves the segregation of syncytial muscle fibres into individual muscle progenitor cells, and recent work has suggested that this might occur through initiation, but not completion, of apoptosis and caspase 3 activation within muscle fibres 49 . These progenitor cells proliferate before they re-differentiate 25 , a process that involves inactivation of the tumour suppressor retinoblastoma (RB) protein.
As mammalian skeletal muscle fails to de-differentiate following injury, it has been proposed that cell cycle regu lators such as RB may constrain mammalian regener ation. Consistent with this notion, simultaneously deleting Rb and the tumour suppressor Arf (a component of the Cdkn2a inhibitor of cell proliferation) from mouse muscle permits de-differentiation 50 . Interestingly, ARF is absent from the newt genome, which may render newt muscle intrinsically more responsive to de-differentiation signals than mammalian muscle.
Microenvironment as a de-differentiation driver or obstacle.
In addition to such cell-intrinsic factors, non-cell-autonomous signals from the microenvironment influence stem cell identity and de-differentiation. In the hair follicle, signals from the surrounding environ ment seem to be the determining factor in stem cell identity, as cells both above and below the bulge are probably exposed to new signals to become cells that can replace ablated bulge cells 33 (FIG. 3a) . At present, the identity of these signals is unknown. Similarly, Although the signals preventing de-differentiation are unknown, the process is likely to involve cAMP, as high cAMP levels in Schwann cells inhibit de-differentiation and promote re-differentiation, possibly through induction of the pro-myelination transcription factor gene Krox20 (also known as Egr2) 52 . Similarly, loss of an inhibitory signal seems to underlie secretory cell de-differentiation following basal cell ablation in the airway 46 (FIG. 3b) . The HIPPO pathway, together with its downstream mediator YAP, could be one such inhibitory signal; YAP is normally absent from secretory cells, but its overexpression within secretory cells induces basal cell de-differentiation 53 . This de-differentiation probably occurs through transcriptional changes, as YAP binds upstream of several genes, including CK5, FGF receptor 2 (FGFR2), epidermal growth factor receptor (EGFR) and integrins α6 and β4, which are more highly expressed in basal stem cells than in secretory cells. Hence, it is enticing to imagine a feedback loop in which signals from stem cells repress de-differentiation in adjacent cells, thus ensuring the proper balance between stem cells and their differentiated progeny. In such a scenario, stem cell ablation would eliminate this inhibitory signal, resulting in the subsequent de-differentiation of adjacent differentiated cells into stem cells.
Thus, de-differentiation is a common response to injury in many tissues across many organisms. In some cases, including the D. melanogaster germ line and mammalian intestine and skin, in which a committed progenitor cell reverts to a stem cell-like state, de-differentiation involves a relatively small step 'backwards' . In other cases, such as the de-differentiation of lung secretory cells following injury, cells appear to travel a greater 'distance' . De-differentiation may also involve changes in cellular identity that follow paths distinct from those that are present during normal development. In zebrafish cardiac regeneration, for example, sarcomeric disassembly and cell cycle re-entry results in cells that are phenotypically and functionally distinct from both cardiomyocytes and functional muscle stem cells. Ultimately, a detailed picture of the changes in chromatin that underlie these shifts in cell identity will be needed in order to understand a tissue's competence for de-differentiation, and how and why different tissues use this path during regeneration.
Morphyllaxis and transdifferentiation
Transdifferentiation is defined as the conversion of a cell from one specialized state to another. The process may be direct, involving a direct conversion, or it may involve a de-differentiation event prior to re-differentiation. Importantly, transdifferentiation requires both repressive and activating effects on gene expression, as genes that are specific to the starting state must be turned off, whereas genes specific to the new state must be turned on. In addition, corresponding changes in functional properties must occur 54 . It should be stressed that there is a difference between what cells do normally and what they are capable of doing under experimental conditions, including in cell culture
. Thus, although many examples of transdifferentiation have been reported in vitro -including some that may have important thera peutic implications [55] [56] [57] -there are only a few examples of bona fide trans differentiation occurring in vivo, and only a small subset of these examples take place under physiological conditions. In this Review, we focus on these in vivo examples of trans differentiation, particularly those that constitute a natural ( physiological) response to injury.
Transdifferentiation in invertebrates.
In Caenorhab ditis elegans, in which all cell lineages have been defined, transdifferentiation has been reported under both experimental and natural (developmental) conditions. Experimentally, a 15-minute pulse of ectopic GATA transcription factor ELT-7 (erythroid-like transcription factor 7) is sufficient to induce pharyngeal margin cells to transdifferentiate into intestinal cells 58 . Transdifferentiation in this setting is direct, as no morphological or functional intermediates have been observed. Instead, cells activate intestinal gene expression and adopt an intestinal phenotype directly before the pharyngeal gene expression programme is repressed.
Furthermore, transdifferentiation occurs naturally during normal development in C. elegans. Specifically, a single hindgut cell crosses germ layers during the second larval stage and transdifferentiates into a neuron in 100% of developing worms 59 . In this example, the hindgut cell first de-differentiates without proliferating, turning off hindgut-specific genes and undergoing an epithelialto-mesenchymal transition. This cell then migrates to its new position, before re-differentiating into a neuron with the corresponding gene expression pattern. Although most studies of vertebrate trans differentiation have been done in the context of injury (and in adult animals), it was recently found that during adrenal gland development, transdifferentiation of differentiated zona glomerulosa cells into zona fasciculata cells is responsible for establishing zonation of the adrenal gland 60 , suggesting that transdifferentiation occurs even during development, when one might expect that all cell lineages would be generated from progenitor cells. 61 , and the linker histone B4, which is normally found in oocytes or in the nuclei of differentiated cells used for somatic cell nuclear transfer (SCNT) 62 . During re-differentiation, these cells express γ-crystallin and other genes specific to the lens cell fate 63 . Although the de-differentiated cells express pluripotency factors, they remain committed to a lens fate, as regenerating iris transplanted into other regions of the newt still results in the generation of lens tissue 64, 65 .
Transdifferentiation in amphibians.

Transdifferentiation in mammals.
Studies of transdifferentiation in mammals have found examples of both forced transdifferentiation through the expression of ectopic factors, and physiological transdifferentiation, in which injury or other signals induce cells to change fate. One example of forced transdifferentiation is the direct conversion of cardiac fibroblasts -both in vitro and in vivo -into cardiomyocytes following expression of transcription factor GATA4, myocyte-specific enhancer factor 2C (MEF2C) and T-box transcription factor TBX5 (REFS 66-68).
Another example of forced differentiation involves pancreatic β-cells, in which the delivery of three transcription factors that are known to play an important part in β-cell development -pancreas/duodenum homeobox protein 1 (PDX1), MAFA and neurogenin 3 (NGN3), collectively known as PMN -was sufficient to turn pancreatic exocrine cells into β-like cells 69 . Although there are various examples of such forced transdifferentiation, we focus this section on examples of physiological transdifferentiation, in which organisms alter cellular identity as part of a natural injury response.
The best examples of physiological transdifferentiation in mammals come from two developmentally related tissues: the liver and the pancreas. The liver is composed primarily of hepatocytes, which perform most of its metabolic and synthetic functions, and biliary epithelial cells (BECs), which line the bile ducts and are crucial for carrying bile out of the liver 70 . Following injury to the liver or ectopic activation of signalling pathways (as detailed below), hepatocytes can change fate, turning off hepatocyte-specific genes and turning on markers of BECs [71] [72] [73] (FIG. 4a) . Analysis of cell size, ultra-structural appearance and mRNA expression indicate that the transdifferentiated cells more closely resemble BECs than hepatocytes 72 . As early progenitor markers of hepatoblasts were not observed 71 , it seems that these In adult islets, α-cells proliferate and begin to transdifferentiate directly into insulin-producing cells. Although these transdifferentiated cells are functional and produce insulin, they still maintain some α-cell gene expression, suggesting that they are not fully transdifferentiated. In juvenile islets, δ-cells proliferate and turn on δ-cell-specific genes. These cells de-differentiate to neurogenin 3 (NGN3) + progenitor cells, then re-differentiate as β-cells. In this example, different pathways may lead to the restoration of islet cells.
Pancreatic islets of Langerhans
Endocrine cells in the pancreas that are responsible for producing the hormones used for glucose management. The process occurs over a prolonged period of time (weeks) and involves stepwise changes in gene expression (FIG. 4a) . Thus, whereas many cells undergo a complete and stable conversion to BECs, some hepatocytes initiate but do not complete the transdifferentiation process, reverting back to a hepatocyte fate when the reprogramming stimulus is removed 72 .
Owing to the central role of pancreatic β-cells in the pathogenesis of diabetes, the pancreas has also been a major focus of transdifferentiation research. In addition to β-cells, the pancreatic islets of Langerhans contain glucagon-producing α-cells and somatostatin-producing δ-cells 74 . In type I diabetes mellitus (T1DM), β-cells are attacked by the immune system, leaving patients with an insufficient number of insulin-producing β-cells 75 . The finding that T1DM can be successfully treated by transplanting patients with cadaver-derived islets has inspired many researchers to try to generate new β-cells in vitro 76 .
We have already seen that overexpression of the PMN factors in the exocrine pancreas can induce exocrine cells to take on a β-cell-like phenotype, and other approaches to forced differentiation, such as administration of EGF and ciliary neurotropic factor (CNTF) to hypoglycaemic animals, have yielded similar results 77 . In addition, partial β-cell transdifferentiation has been observed following mis-expression of the PMN transcription factors in the proximal intestine -a region of the gut tube that is embryonically related to the pancreas 78 -or when subsets of these factors have been expressed in various tissues [79] [80] [81] . But what about transdifferentiation under physiological conditions? Beyond these examples of experimentally prompted transdifferentiation, it is also clear that endocrine cell plasticity is evoked as a physiological response to β-cell damage. Specifically, ablation of more than 99% of β-cells in the pancreas causes a substantial number of glucagon-producing α-cells to transdifferentiate into insulin-producing β-like cells 82 . This change in cell identity has profound physiological consequences, as those mice with robust transdifferentiation no longer required exogenous insulin 6 months after β-cell ablation. Interestingly, and in contrast to some other examples of transdifferentiation, the reprogrammed β-cells still expressed some α-cell-specific genes, indicating that functionally relevant transdifferentiation does not require complete repression of the transcriptional programme of the starting cell type.
More recent work found that juvenile mice use a different mechanism of transdifferentiation following massive β-cell loss, in which somatostatin-producing δ-cells become β-like cells 83 . Unlike adult α-cell transdifferentiation, juvenile δ-cell transdifferentiation engages a de-differentiation and re-differentiation pathway that requires re-expression of the NGN3 transcription factor, which is a marker of embryonic endocrine progenitor cells 83 . These results suggest that cells reach similar endpoints via divergent sources and paths, depending on cellular context (FIG. 4b) . In addition, it is likely that these transdifferentiation 'routes' are bidirectional, as several studies have shown that β-cells can be converted to α-cells in vivo through a number of experimental approaches 84, 85 (FIG. 4b) .
Finally, whereas cellular plasticity may be a part of the solution when it comes to T1DM, it may be part of the problem in type 2 diabetes mellitus (T2DM). T2DM is the more common form of the disease and reflects the combined effects of insulin resistance (whereby target tissues no longer respond to the same levels of insulin) and reduced β-cell function. It has long been thought that decreased β-cell function was caused by the loss of β-cells over time owing to chronic stress. However, several recent studies have suggested that β-cell transdifferentiation, rather than death, contributes the loss of β-cell function that drives T2DM. Specifically, it was reported that in mouse models of T2DM, β-cells took on features of other endocrine cell types or stem cells, implicating cell plasticity as a source of β-cell dysfunction 86 . Evidence supporting this view has recently been obtained from studies of human individuals with T2DM 87 .
Mechanisms of transdifferentiation
Transdifferentiation involves massive cellular reorganization at the transcriptional, post-transcriptional and cell-biological levels. Moreover, the extracellular signals that drive transdifferentiation must be tightly regulated in a spatiotemporal-specific manner; without such tight control, alterations in cell identity could lead to marked disruptions in tissue function. Although the intra cellular and extracellular factors that are required for cells to change identity have been identified in a few specific cases, most of the molecular drivers of cellular plasticity remain unknown. Nevertheless, chromatin remodelling, which is the process by which new transcriptional programmes are activated and old ones are silenced, is likely to lie at the centre of this process.
Chromatin modifications in invertebrates and amphibians. The intestinal-to-neuronal cell identity switch in C. elegans provides one example of the importance of chromatin modification in transdifferentiation. Genetic screens for genes that interrupted this event revealed jumonji domain 3.1 (jmjd3.1) -encoding a demethylase that removes a transcriptionally repressive methyl mark from histone 3 Lys27 (H3K27) -as essential for activating the motor neuron transcriptional programme. Similarly, mutations in SET domain-containing 1 (set1), which activates transcription by methylating H3K4, also inhibit transdifferentiation 88 . For transdifferentiation to occur, multiple regions of chromatin must adopt an 'open' configuration that is more accessible to transcription factors and chromatinmodifying enzymes, permitting global changes in transcription. In this respect, it is perhaps not surprising that Sox2 and Klf4 are expressed during newt lens regeneration 61 . Furthermore, the linker histone B4, which facilitates chromatin remodelling, is required for iris-to-lens transdifferentiation 62 . These chromatin changes are likely to be essential for the cells to repress iris-specific genes and activate lens-specific genes. One such gene is γ-crystallin, the expression of which is almost absent when histone B4 is knocked down.
Metaplasia
Changes in tissue whereby one cell type is replaced by another, often associated with increased cancer risk.
Signalling pathways in the mammalian liver and pancreas. Developmentally important signalling pathways are crucial for transdifferentiation. In the embryonic liver, NOTCH signalling regulates bile duct development by coordinating differentiation and morphogenesis 89 , whereas in the adult liver, ectopic NOTCH signalling converts hepatocytes to a biliary fate 71 . The transdifferentiation process requires the NOTCH-dependent DNAbinding protein RBPJ and occurs in a stepwise fashion that takes days to weeks, thus resembling reprogramming to pluripotency 90 . The signals that activate NOTCH during hepatocyte transdifferentiation remain unknown, but recent work has implicated the HIPPO pathway and its downstream transcriptional activator YAP. Like NOTCH, the HIPPO pathway is involved in embryonic liver development, in which YAP is required for biliary development 91 . Ectopic YAP expression in adult hepatocytes leads to biliary transdifferentiation that is partially NOTCH-dependent, as YAP is bound to the promoters of both NOTCH2 and SOX9 (an earlier marker of biliary cells) in de-differentiated cells 92 . Together, these findings suggest that NOTCH and HIPPO function in concert to regulate biliary identity in the liver (FIG. 4b) .
As noted above, studies investigating transdifferentiation in the pancreas suggest that developing and adult mice use different cellular substrates to generate new β-cells following injury 82, 83 . These studies leave open several intriguing questions regarding cell plasticity during maturation and ageing. It is currently unclear how pancreatic α-or δ-cells sense the decreased quantity of β-cells, and why transdifferentiation from α-cells is direct whereas transdifferentiation from δ-cells involves a de-differentiation intermediate. By analogy with the basal cells of the lung, it is possible that β-cells send an inhibitory signal that prevents transdifferentiation under normal circumstances and that is disrupted following β-cell ablation. Alternatively, α-and δ-cells may be differentially sensitive to decreasing levels of insulin.
Initiation versus maintenance of new identities
Cellular reprogramming, whether by de-differentiation or transdifferentiation, requires dramatic changes in gene expression. Such changes are needed to activate genes associated with the new fate and to inhibit genes associated with the previous fate. In some cases, 'master regulators' that control the expression of many genes, such as MYOD, may control the process 8 , whereas in other cases, specific changes in chromatin may function to establish a new fate. Regardless of how they are established, changes in gene expression are probably maintained in the long term by alterations in chromatin structure 62, 88, 93 , such as histone modifications, which can turn off genes of the old fate and turn on genes of the new fate.
In this regard, it is worth noting that transdifferentiation need not be an 'all or nothing' phenomenon. For example, cellular phenotype may change as a result of transcriptional or post-transcriptional changes, such as overexpression of the YAP transcription factor in the de-differentiation of secretory cells in the lung, but then revert back in the absence of subsequent epigenetic modifications when the stimulus is removed. Another case in point is hepatocyte transdifferentiation, in which some transdifferentiating cells revert back to the hepatocyte fate when the injury is resolved. Cells that have undergone stable transdifferentiation seem to be maintained in their new (biliary) identity, whereas cells that are in the midst of the transdifferentiation process can return to their original hepatocyte identity 72 . Thus, 'intermediate' cells may be more competent to revert to the starting fate than those cells that have undergone a 'complete' transdifferentiation.
Cellular plasticity, metaplasia and cancer Metaplasia describes changes within tissues whereby one cell type is replaced with another 94 . Although the phenomenon may involve transdifferentiation, it has been proposed that metaplasia can also result from cell migration or altered cell fate decisions during normal differentiation. Tissue metaplasia is frequently associated with a predisposition to cancer 95, 96 (for examples, see TABLE 1) . One of the most common examples of metaplasia is Barrett oesophagus, in which the normal squamous epithelium of the oesophagus is replaced by columnar cells with features of the intestinal epithelium 97 . Barrett metaplasia is strongly associated with the development of oesophageal adenocarcinoma 98, 99 , which has led to the notion that transdifferentiation is associated with oncogenic risk. However, the extent to which the Barrett-associated risk of cancer is due to transdifferentiation remains unclear. Whether or not Barrett metaplasia is a true metaplastic event, uncontrolled cell plasticity has been hypothesized to be . Specifically, mouse models of cancerparticularly pancreas and liver cancer -provide strong evidence that transdifferentiation plays a central part in cancer-initiating events.
Most pancreatic cancers -and their neoplastic precursors known as pancreatic intraepithelial neoplasias (PanINs) -have the histological appearance of ductal cells 101 . However, several studies suggest that PanINs arise from phenotypically distinct acinar cells through a process termed acinar-to-ductal metaplasia [101] [102] [103] [104] . For instance, a recent study found that deletion of pancreasspecific transcription factor 1a (Ptf1a), which is a gene controlling acinar cell fate, increased PanIN development and subsequently increased the rate of pancreatic cancer 105 . It is unclear why acinar cell transdifferentiation predisposes cells to cancer, but it may be that only particular cell types are susceptible to the growth-promoting effects of certain oncogenic mutations (that is, the right mutations occurring in the right cells at the right time).
Similarly, transdifferentiation events may precede further oncogenic steps during the development of intrahepatic cholangiocarcinoma (ICC), a cancer of the small bile ducts of the liver. Although ICCs have a ductal (biliary) appearance histologically, several studies have suggested that they originate from phenotypically distinct hepatocytes 106, 107 . Although these studies did not investigate whether changes in cell identity occur before or after other oncogenic events, it is enticing to speculate that the same dramatic changes in gene expression (and chromatin structure) that underlie cellular plasticity could also lead to dysregulated expression of oncogenes or repression of tumour suppressor genes.
Interestingly, some of the same signals that produce cellular reprogramming can also be oncogenic. As discussed above, NOTCH signalling induces hepatocytes to transdifferentiate into biliary cells, and activation of NOTCH in hepatic cells results in hepatocellular carcinomas with biliary features 108 or frank ICC 106 . YAP, which similarly induces hepatocyte-to-biliary transdifferentiation in the liver, is also associated with the formation of liver cancers 109 . These findings suggest that the signals that allow adult cells to change their identity may put tissues at increased risk of malignant trans formation. Such an association could provide an additional explanation for the well-appreciated association between tissue inflammation following chronic injury (the in vivo stimulus for transdifferentiation) and cancer.
Conclusions and perspectives
It may be useful to think of the cells in a tissue as members of a team, each having a specific position and part to play. In the hierarchy of such a team, the group leader has a particularly crucial responsibility, dictating strategy and maintaining the overall integrity of the group. As long as the leader is in charge, the rest of the team operates as intended. However, if the leader is incapacitated, another team member must take on the job, at least temporarily. This, of course, is 'de-differentiation' . Likewise, team members must be able to 'transdifferentiate' and take on the roles of other team members, even if these are not their normal tasks. Such plasticity in the workplace allows the team to function without falling apart, just as it does in our tissues.
At the cellular level, changes in identity can occur experimentally through the activation of specific signalling pathways, or physiologically as a response to signals released during injury and inflammation. These processes are tightly regulated, as uncontrolled plasticity could destabilize tissues and/or lead to cancer. The fact that cells show plasticity in the setting of injury indicates that de-differentiation and transdifferentiation are important for organ physiology and regeneration. However, the extent and precise role of cellular plasticity remains to be defined, and the widespread existence of the phenomenon raises a number of important questions.
To begin, one might ask why some tissues, particularly those that harbour stem cells, exploit de-differentiation. Although the answer to this question is unknown, we speculate that tissues utilize de-differentiation as a backup system to generate reserve stem cells should the original stem cell pool be lost. In the examples of lung, intestine and skin discussed in this Review, de-differentiation may result in a restoration of the stem cell pool after injury or ablation. Indeed, there is evidence that stem cells passively or actively inhibit de-differentiation, as the result of an ongoing dialogue between stem cells and their progeny.
One can also ask the converse question: if cells can undergo de-differentiation and transdifferentiation, then why maintain a stem cell pool in the first place? Again, the answer is unclear, but it may indicate that plasticity comes at a cost. In particular, the epigenetic changes that are required for a cell to change its identity may also predispose it to cancer 110 , and hence reducing the frequency with which cells change identity might reduce the risk of malignant transformation. Alternatively, differentiation from stem cells might provide a more efficient or spatially defined way to control cellular identity. If this is the case, then de-differentiation and transdifferentiation might be the preferred mechanism of maintaining tissue homeostasis only when normal spatial signals for differentiation are disrupted by injury.
The ability to exploit cellular plasticity to generate the necessary cell types in vivo has tremendous therapeutic potential (TABLE 2) . Although most examples of plasticity discussed in this Review were conducted in model organisms, it is likely that the cellular relationships identified in these studies are conserved in humans. For example, one study found that human hepatocytes transplanted into mouse livers undergo transdifferentiation into biliary cells 72 , indicating that human hepatocytes also undergo transdifferentiation as a physiological response to injury. Generating new β-cells in the pancreas as a treatment for diabetes has high priority in the field of regenerative medicine, and transdifferentiation -from either α-cells or other endoderm derivatives -is an attractive approach.
Before such strategies can be applied, a deeper mechanistic understanding of cellular plasticity is needed. Are there generalized principles of epigenetic remodelling that underlie all changes in adult cellular identity, or is every case different? What are the spatial cues that establish functional cellular arrangements following de-differentiation and transdifferentiation? Finally, what are the mechanisms by which cellular plasticity might predispose tissues to cancer? Hopefully, answering these questions will open up new opportunities for cell-based therapies for disease, using approaches that will rely on cells already present in the body.
Note added in proof
In newly published work, Tetteh et al. 122 report that committed enterocyte progenitor cells -marked by the expression of intestinal alkaline phosphatase (ALPi) -de-differentiate upon ablation of LGR5-expressing intestinal stem cells, corroborating prior observations of adaptive cellular de-differentiation in vivo. .
